© 2004 by Oxford University Press
© 2004 Oxford University Press
NEWS |
Awards, Appointments, Announcements
The 2004 Albert Lasker Medical Research Awards were presented to
five recipients at a ceremony October 1 in New York. The 2004 Lasker Award for Basic Medical Research was shared by Pierre Chambon, M.D., of the Institute of Genetics and Molecular and Cellular Biology in Strasbourg, France; Ronald M. Evans, Ph.D., of the Salk Institute for Biological Studies in La Jolla, Calif.; and Elwood V. Jensen, Ph.D., of the University of Chicago. The trio was honored for the discovery of the superfamily of nuclear hormone receptors and the elucidation of a unifying mechanism that regulates embryonic development and diverse metabolic pathways.
Charles Kelman, M.D., who was a professor at the New York Medical College prior to his death this past June, will receive posthumously the 2004 Lasker Award for Clinical Medical Research for revolutionizing the surgical removal of cataracts through noninvasive surgery.
The 2004 Lasker Award for Special Achievement in Medical Science went to Matthew Meselson, Ph.D., of Harvard University in Cambridge, Mass., for a lifetime career that has combined discoveries in molecular biology—such as his work with Franklin Stahl that showed how DNA duplicates itself—with leadership in public policy aimed at eliminating chemical and biological weapons.
David S. Alberts, M.D., director of Cancer Prevention and Control at
the Arizona Cancer Center in Tucson, was selected as the recipient of the
American Association for Cancer Research/Cancer Research and Prevention
Foundation Award for Excellence in Cancer Prevention Research.
Gloria Coronado, Ph.D., joined the faculty of the Fred Hutchinson
Cancer Research Center in Seattle as an assistant member of the Public Health
Sciences Division. Coronado is a cancer researcher who focuses on health
issues that affect Latinos.
The Memorial Sloan-Kettering Cancer Center in New York has made two
appointments:
David G. Pfister, M.D., has been named chief of the newly created Head and Neck Medical Oncology Service in the Department of Medicine's Division of Solid Tumor Oncology.
Joseph M. Huryn, D.D.S., has been named chief of the Dental Service in the Department of Surgery. Huryn has been acting chief since July 2003.
Hyung Kim, M.D., has been appointed to the Department of Urologic
Oncology at Roswell Park Cancer Institute in Buffalo, N.Y.
Eric Radany, M.D., Ph.D., has joined the Division of Radiation
Oncology at the City of Hope Cancer Center in Duarte, Calif. Radany was
previously at the University of California at Irvine College of Medicine and
the Chao Family Comprehensive Cancer Center.
Susan T. Mayne, Ph.D., professor of epidemiology in the Department
of Epidemiology and Public Health at Yale University School of Medicine in New
Haven, Conn., has been selected to serve as a member of the National Cancer
Institute's Board of Scientific Counselors. Mayne's term will last until June
30, 2009.
Louise B. Grochow, M.D., has been named global product medical
director for emerging oncology products at AstraZeneca. She was previously
chief of the Investigational Drug Branch (IDB) at the National Cancer
Institute. Anthony J. Murgo, M.D., took over as IDB acting chief.
David Hunter, Sc.D., Vincent L. Gregory Professor of Cancer
Prevention at the Harvard School of Public Health, has been appointed a
National Cancer Institute Eminent Scholar in the Intramural Research
Program.
Albert F. LoBuglio, M.D., is stepping down from his role as director
of the University of Alabama at Birmingham Comprehensive Cancer Center but
will continue to serve as a Cancer Center faculty member. Peter D. Emanuel,
M.D., a senior scientist at the Cancer Center, will serve as acting
director until a national search is completed.
Geoffrey Weiss, M.D., has been appointed Chief of the Division of
Hematology-Oncology and Deputy Director of the Cancer Center for Clinical
Affairs and Clinical Research at the University of Virginia Health System in
Charlottesville. Weiss was previously at the University of Texas at San
Antonio.
The 2004 Nobel Prize in Chemistry was awarded to Aaron Ciechanover,
M.D., D.Sc., and Avaram Hershko, M.D., Ph.D., of the department of
biochemistry at the Israel Institute of Technology in Haifa, and Irwin
Rose, Ph.D., professor emeritus at the University of California at Irvine,
for their discovery of the process by which cells label proteins for
degradation.
David Brown, M.D., has been named the Edward Rotan Distinguished
Professor and chair of anesthesiology an pain medicine at the University of
Texas M. D. Anderson Cancer Center in Houston. Brown was previously at the
University of Iowa College of Medicine.
Clarification
A News article in the July 7 issue of the Journal ("BRCA1 Discovery Led to Patent Debate, Genetic Screening," p. 986) stated that a 2002 article in the New England Journal of Medicine found that prophylactic oophorectomy reduced the risk of ovarian cancer by 85% and breast cancer by 25% in BRCA mutation carriers. The percentages cited were the authors' conservative estimates of their results; the calculated risk reductions in the group of subjects in the study were 96% for ovarian cancer and 53% for breast cancer.
CiteULike 
Connotea 
Del.icio.us What's this?
| ||||||||||||||||||||||||||||||||||||||||||||||